Trials / Completed
CompletedNCT05339633
Study in Healthy Adult Female Subjects
An Open Label Phase 1 Study in Healthy Adult Female Subjects to Determine the Mass Balance Recovery, Absorption, Metabolism, and Excretion of [14C]-D-0502 Following Single Oral Dose Administration
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- InventisBio Co., Ltd · Industry
- Sex
- Female
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
An Open Label Phase 1 Study in Healthy Adult Female Subjects to Determine the Mass Balance Recovery, Absorption, Metabolism, and Excretion of \[14C\] D-0502 Following Single Oral Dose Administration
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | [14C]-D-0502 | Drug: \[14C\]-D-0502 and D-0502 |
Timeline
- Start date
- 2022-03-29
- Primary completion
- 2022-08-02
- Completion
- 2022-10-31
- First posted
- 2022-04-21
- Last updated
- 2023-04-06
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05339633. Inclusion in this directory is not an endorsement.